Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02171325
What this trial is testing

Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment

Who this might be right for
Small Cell Lung Cancer
Guangdong Association of Clinical Trials 54
Early research (Phase 1)Study completedNCT00611728
What this trial is testing

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Who this might be right for
Glioblastoma
Duke University 25
Large-scale testing (Phase 3)Study completedNCT00144989
What this trial is testing

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Who this might be right for
Small-Cell-Lung Cancer
Haruhiko Fukuda 281
Testing effectiveness (Phase 2)UnknownNCT00343668
What this trial is testing

S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Korean Cancer Study Group 44
Testing effectiveness (Phase 2)Study completedNCT01281761
What this trial is testing

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

Who this might be right for
Metastatic Colorectal Cancer
Samsung Medical Center 52
Testing effectiveness (Phase 2)UnknownNCT02848794
What this trial is testing

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

Who this might be right for
High-grade Glioma
The First People's Hospital of Lianyungang 40
Large-scale testing (Phase 3)Study completedNCT00154102
What this trial is testing

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Who this might be right for
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 1,221
Early research (Phase 1)Study completedNCT05086822
What this trial is testing

Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT00111761
What this trial is testing

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Amgen 43
Large-scale testing (Phase 3)Study completedNCT00389870
What this trial is testing

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

Who this might be right for
Colorectal Cancer
University of Leeds 1,198
Large-scale testing (Phase 3)Looking for participantsNCT06555003
What this trial is testing

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

Who this might be right for
Liver NeoplasmColorectal Cancer Metastatic
Tehran University of Medical Sciences 116
Large-scale testing (Phase 3)Study completedNCT00193596
What this trial is testing

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Who this might be right for
Neoplasms, Unknown Primary
SCRI Development Innovations, LLC 198
Testing effectiveness (Phase 2)UnknownNCT00502762
What this trial is testing

Topotecan for Irinotecan-Refractory SCLC

Who this might be right for
Lung CancerRefractory to Chemotherapy
Gachon University Gil Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04753879
What this trial is testing

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableStudy completedNCT01840280
What this trial is testing

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 324
Testing effectiveness (Phase 2)Looking for participantsNCT07356973
What this trial is testing

Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

Who this might be right for
Glioblastoma
CRISM Therapeutics LTD 147
Not applicableLooking for participantsNCT06375473
What this trial is testing

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Peking Union Medical College Hospital 3,000
Not applicableUnknownNCT05889325
What this trial is testing

To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)
Peking University Cancer Hospital & Institute 100
Early research (Phase 1)Study completedNCT00497497
What this trial is testing

PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00191984
What this trial is testing

The Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Eli Lilly and Company 46
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation